A study comparing plasma levels of SAP at baseline, 2 weeks, and 12 weeks in patients with MDD receiving escitalopram monotherapy (an SSRI treatment) for 8 to 12 weeks34 discovered a significant increase in SAP levels in the depression group compared with the control group at baseline. Here, APCS is linked to depressive symptom measurement.